Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ACHV | US
-0.13
-3.13%
Healthcare
Biotechnology
30/06/2024
24/04/2026
4.02
4.15
4.15
3.94
Achieve Life Sciences Inc. a clinical-stage pharmaceutical company develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada the United States and the United Kingdom. The company offers cytisinicline a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences Inc. is based in Vancouver Canada.
View LessPrice Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
198.4%1 month
146.8%3 months
114.7%6 months
93.7%-
-
4.10
0.42
0.27
-2.42
-
-
-25.14M
138.05M
138.05M
-
-
-
-
-105.95
31.50
12.01
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.20
Range1M
2.68
Range3M
3.08
Rel. volume
0.45
Price X volume
3.14M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Fate Therapeutics Inc | FATE | Biotechnology | 1.33 | 151.46M | 0.76% | n/a | 25.33% |
| Spero Therapeutics Inc | SPRO | Biotechnology | 2.74 | 148.09M | -2.14% | 3.76 | 6.13% |
| CABALETTA BIO INC. | CABA | Biotechnology | 2.95 | 144.10M | -3.28% | n/a | 3.71% |
| TransCode Therapeutics Inc. Common Stock | RNAZ | Biotechnology | 8.52 | 143.72M | -1.73% | 0.00 | 17.19% |
| ELEDON PHARMACEUTICALS INC | ELDN | Biotechnology | 3.465 | 143.39M | -3.48% | 6.60 | -7.70% |
| BriaCell Therapeutics Corp. Common Shares | BCTX | Biotechnology | 3.88 | 139.25M | 4.02% | n/a | 0.00% |
| Connect Biopharma Holdings Limited American Depositary Shares | CNTB | Biotechnology | 2.52 | 139.24M | 0.00% | n/a | 0.29% |
| Citius Pharmaceuticals Inc | CTXR | Biotechnology | 0.77 | 139.16M | -17.47% | n/a | 0.37% |
| Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 7.37 | 136.74M | 23.45% | n/a | 571.64% |
| AVTX | AVTX | Biotechnology | 13.92 | 135.02M | -5.63% | n/a | -80.47% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 36.11 | 103.70M | 0.00% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.11 | 99.53M | 1.16% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.765 | 73.67M | 1.69% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.9 | 70.43M | 6.56% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 21.77 | 33.16M | -2.81% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.57 | 11.01M | -3.37% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5165 | 7.55M | -0.67% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.38 | 3.52M | 0.23% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.199 | 1.89M | 1.38% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.27 | 699.77K | -6.62% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.42 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.10 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 114.68 | 72.80 | Riskier |
| Debt to Equity | 0.42 | -1.23 | Expensive |
| Debt to Assets | 0.27 | 0.25 | Par |
| Market Cap | 138.05M | 3.66B | Emerging |